Paper - WANFANG MED ONLINE

You Position: Home > Paper

Application of ultrasensitive thyroglobulin assays in the follow-up of differentiated thyroid carcinoma

( views:377, downloads:193 )

Author:: No author available

Journal Title:: Chinese Journal of Nuclear Medicine and Molecular Imaging

Issue:: 5

DOI:: 10.3760/cma.j.issn.2095-2848.2016.05.023

Key Word:: 甲状腺肿瘤;甲状腺球蛋白;发展趋势;Thyroid neoplasms;Thyroglobulin;Trends

Abstract： DTC is the most common endocrine carcinoma and its routine treatment consists of total thyroidectomy and 131I thyroid remnant ablation.Currently,standard follow-up for DTC comprises Tg measurement and neck ultrasound as well as an additional radioiodine scan when indicated.As thyroid cells are assumed to be the only source of Tg in serum,circulating Tg serves as an excellent marker of persistent or recurrent disease in DTC follow-up.With the development of highly sensitive Tg assays,now it is possible to detect very low Tg concentrations which reflect minimal amounts of thyroid tissue without the need for TSH stimulation.This review is to introduce clinical implications of highly sensitive Tg assays.

Reference

[1]卢承慧,左书耀,王登春,等.细针穿刺、超声及甲状腺球蛋白对分化型甲状腺癌清甲后颈部肿大淋巴结诊断价值的比较[J].2014,(4).
[2]孟超,龙文,梁军,等.中低危分化型甲状腺癌术后131I清甲治疗后血清甲状腺球蛋白的变化[J].2013,(4).
[3]买尔哈巴,迪力木拉提·阿不来提,杨香菊,等.甲状腺球蛋白基因多态性与甲状腺球蛋白抗体的相关性[J].2011,(7).
[4]Hermus AR,Schakenraad E,Sweep FC,etc.Assay bias may invalidate decision limits and affect comparability of serum thyroglobulin assay methods: an approach to reduce interpretation differences.[J].2008,394(1).
[5]A. Iervasi,G. Iervasi,M. Ferdeghini,etc.Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer[J].2007,67(3).
[6]Nascimento,C.,Borget,I.,Troalen,F.,etc.Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablation[J].2013,169(5).
[7]Omry G,Shah J,Brokhin M,etc.Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association st[J].2010,20(12).
[8]Zophel K,Wunderlich G,Smith BR.Serum thyroglobulin measurements with a high sensitivity enzyme-linked immunosorbent assay: is there a clinical benefit in patients with differentiated thyroid carcinoma?[J].2003,13(9).
[9]Smith BR,Crook L,Zophel K,etc.A high-sensitivity enzyme-linked immunosorbent assay for serum thyroglobulin.[J].2001,11(9).
[10]Momesso,D.P.,Tuttle,R.M..Update on differentiated thyroid cancer staging[J].2014,43(2).
[11]Feldt-Rasmussen, U.,Profilis, C.,Colinet, E.,etc.Human thyroglobulin reference material (CRM 457)^* 2nd part: Physicochemical characterization and certification[J].1996,54(10).
[12]Giovanella L,Maffioli M,Ceriani L.Postsurgery serum thyroglobulin disappearance kinetic in patients with differentiated thyroid carcinoma.[J].2010,32(5).
[13]Rosario, Pedro Weslley,Mourao, Gabriela Franco,Siman, Thassio Leonardo,etc.Serum Thyroglobulin Measured With a Second-Generation Assay in Patients Undergoing Total Thyroidectomy Without Radioiodine Remnant Ablation: A Prospective Study[J].2015,25(7).
[14]Valle,L.A.,Sipos,J.A.,Khawaja,R.,etc.In thyroidectomized patients with thyroid cancer, a serum thyrotropin of 30??u/ml after thyroxine withdrawal is not always adequate for detecting an elevated stimulated serum thyroglobulin[J].2013,23(2).
[15]Durante,C.,Montesano,T.,Attard,M.,etc.Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: Is there a role for serum thyroglobulin measurement?[J].2012,97(8).
[16]Ceriani L,Giovanella L.High-sensitivity human thyroglobulin (hTG) immunoradiometric assay in the follow-up of patients with differentiated thyroid cancer.[J].2002,40(5).
[17]Luca Giovanella,Giorgio Treglia,Ramin Sadeghi,etc.Unstimulated highly sensitive thyroglobulin in follow-up of differentiated thyroid cancer patients: a meta-analysis.[J].2014,99(2).
[18]Smallridge RC,Grebe S,Fatourechi V,etc.Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients.[J].2007,92(1).
[19]O'Kane DJ,Singh RJ,Morris JC,etc.Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays.[J].2003,88(7).
[20]Feldt-Rasmussen, U.,Profilis, C.,Colinet, E.,etc.Human thyroglobulin reference material (CRM 457)^* 1st part: Assessment of homogeneity, stability and immunoreactivity[J].1996,54(10).
[21]Verburg FA,Waschle K,Reiners C,etc.Heterophile antibodies rarely influence the measurement of thyroglobulin and thyroglobulin antibodies in differentiated thyroid cancer patients.[J].2010,42(10).
[22]Spriano G,Sacchi A,Maffioli M,etc.Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated assay and imaging procedures.[J].2006,44(5).
[23]F, Pacini,M, Schlumberger,H, Dralle,etc.[European consensus on the management of patients with differentiated carcinoma of the thyroid from follicular epithelium].[J].2008,167(1).
[24]Lopresti JS,Spencer CA.Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer.[J].2008,4(4).
[25]U, Feldt-Rasmussen,M, Schlumberger.European interlaboratory comparison of serum thyroglobulin measurement.[J].1988,11(3).
[26]Kazarosyan M,Spencer CA,Fatemi S,etc.Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.[J].1998,83(4).
[27].Laboratory services for thyroglobulin and implications for monitoring of differentiated thyroid cancer[J].2009,62(5).
[28]Toubert ME,Tenenbaum F,Gira,etc.Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients.[J].2007,92(7).
[29]Annicchiarico C,Zucchelli GC,Bottoni A,etc.Diagnostic performance of a new highly sensitive thyroglobulin immunoassay.[J].2004,182(2).
[30]Haugen, Bryan R.,Alexander, Erik K.,Bible, Keith C.,etc.2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J].2016,26(1).